AAAAAA

   
Results: 1-12 |
Results: 12

Authors: SINGH M LI XM WANG HY MCGEE JP ZAMB T KOFF W WANG CY OHAGAN DT
Citation: M. Singh et al., CONTROLLED-RELEASE MICROPARTICLES AS A SINGLE-DOSE DIPHTHERIA TOXOID VACCINE - IMMUNOGENICITY IN SMALL ANIMAL-MODELS, Vaccine, 16(4), 1998, pp. 346-352

Authors: ISHII N FUKUSHIMA J KANEKO T OKADA E TANI K TANAKA SI HAMAJIMA K XIN KQ KAWAMOTO S KOFF W NISHIOKA K YASUDA T OKUDA K
Citation: N. Ishii et al., CATIONIC LIPOSOMES ARE A STRONG ADJUVANT FOR A DNA VACCINE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, AIDS research and human retroviruses, 13(16), 1997, pp. 1421-1428

Authors: KEEFER MC WOLFF M GORSE GJ GRAHAM BS COREY L CLEMENTSMANN ML VERANIKETTER N ERB S SMITH CM BELSHE RB WAGNER LJ MCELRATH MJ SCHWARTZ DH FAST P CHARRON K REYNOLDS MJ ZIMMERMAN E JONES K HARRIS M FREY SE KENNEDY DJ ISRAEL H BERRY C READ B SPITZ T PACATTE T DOLIN R REICHMAN RC LAMBERT J DEMETER L ROBERTS NJ PUGLIESE M BERGER D BURKE J SCOTT T BLACKSTONE E WRIGHT PF BRAEUNER M RYBCZYK GK CRUMBO K BATTLE W CORNELL R OWENS D JENNINGS M HARBISON MA HENSMAN BJ BARR P STABLEIN DM VOSS T PALLAS S LOMAX N KOFF W LAWRENCE D JOHNSTON M SAVARESE B WESCOTT SL
Citation: Mc. Keefer et al., SAFETY PROFILE OF PHASE-I AND PHASE-II PREVENTIVE HIV TYPE-1 ENVELOPEVACCINATION - EXPERIENCE OF THE NIAID AIDS VACCINE EVALUATION GROUP, AIDS research and human retroviruses, 13(14), 1997, pp. 1163-1177

Authors: SINGH M LI XM MCGEE JP ZAMB T KOFF W WANG CY OHAGAN DT
Citation: M. Singh et al., CONTROLLED-RELEASE MICROPARTICLES AS A SINGLE-DOSE HEPATITIS-B VACCINE - EVALUATION OF IMMUNOGENICITY IN MICE, Vaccine, 15(5), 1997, pp. 475-481

Authors: SINGH M HIOE C QIU H LI XM WANG CY KOFF W ZAMB T NIXON DF
Citation: M. Singh et al., CTL INDUCTION USING SYNTHETIC PEPTIDES DELIVERED IN EMULSIONS - CRITICAL ROLE OF THE FORMULATION PROCEDURE, Vaccine, 15(16), 1997, pp. 1773-1778

Authors: SINGH M MCGEE JP LI XM KOFF W ZAMB T WANG CY OHAGAN DT
Citation: M. Singh et al., BIODEGRADABLE MICROPARTICLES WITH AN ENTRAPPED BRANCHED OCTAMERIC PEPTIDE AS A CONTROLLED-RELEASE HIV-1 VACCINE, Journal of pharmaceutical sciences, 86(11), 1997, pp. 1229-1233

Authors: SINGH M LI XM WANG HY MCGEE JP ZAMB T KOFF W WANG CY OHAGAN DT
Citation: M. Singh et al., IMMUNOGENICITY AND PROTECTION IN SMALL-ANIMAL MODELS WITH CONTROLLED-RELEASE TETANUS TOXOID MICROPARTICLES AS A SINGLE-DOSE VACCINE, Infection and immunity, 65(5), 1997, pp. 1716-1721

Authors: HIOE CE QIU H CHEND PD BIAN ZN LI ML LI J SINGH M KUEBLER P MCGEE P OHAGAN D ZAMB T KOFF W ALLSOPP C WANG CY NIXON DF
Citation: Ce. Hioe et al., COMPARISON OF ADJUVANT FORMULATIONS FOR CYTOTOXIC T-CELL INDUCTION USING SYNTHETIC PEPTIDES, Vaccine, 14(5), 1996, pp. 412-418

Authors: NIXON DF HIOE C CHEN PD BIAN ZN KUEBLER P LI ML QIU H LI XM SINGH M RICHARDSON J MCGEE P ZAMB T KOFF W WANG CY OHAGAN D
Citation: Df. Nixon et al., SYNTHETIC PEPTIDES ENTRAPPED IN MICROPARTICLES CAN ELICIT CYTOTOXIC T-CELL ACTIVITY, Vaccine, 14(16), 1996, pp. 1523-1530

Authors: HIOE C BIAN ZN QIU H DECHEN P KUEBLER P WU A RICHARDSON J MCGEE P OHAGAN D KOFF W WANG CY NIXON DF
Citation: C. Hioe et al., OPTIMAL DOSE FOR CTL INDUCTION BY SYNTHETIC LIPOPEPTIDES, Journal of cellular biochemistry, 1995, pp. 144-144

Authors: POTTS BJ FIELD K MASCOLA J WANG CY KOFF W
Citation: Bj. Potts et al., NEUTRALIZATION OF PRIMARY FIELD ISOLATES OF HIV-1 FROM GLOBALLY DIVERSE CLADES, AIDS research and human retroviruses, 10, 1994, pp. 190000056-190000056

Authors: BELSHE RB CLEMENTS ML DOLIN R GRAHAM BS MCELRATH J GORSE GJ SCHWARTZ D KEEFER MC WRIGHT P COREY L BOLOGNESI DP MATTHEWS TJ STABLEIN DM OBRIEN FS EIBL M DORNER F KOFF W
Citation: Rb. Belshe et al., SAFETY AND IMMUNOGENICITY OF A FULLY GLYCOSYLATED RECOMBINANT GP160 HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VACCINE IN SUBJECTS AT LOW-RISK OF INFECTION, The Journal of infectious diseases, 168(6), 1993, pp. 1387-1395
Risultati: 1-12 |